|
|

Courses by Type
Courses by Date
Courses by Location
Certification Programs
Client Endorsements
On-Site Training
Course Catalog
Course Locations
& Transportation
Accreditation
About Us
Press Releases
Frequently Asked
Questions
Employment
Opportunities
Suggest a Course
Site Map
|
Preparing the CMC Section for NDAs/INDs/CTDs
COURSE AGENDA
DAY ONE
ICH Process and CTD Organization
- ICH Background/Working Groups
- ICH 5-Step Process
- CTD Modules
Requirements for Drug Substance
- S.1 General Information: Nomenclature, Structure, General Properties
- S.2 Manufacture
- Manufacturers
- Description of Manufacturing Process and Process Controls
- Flow diagram
- Process Narrative
- Process Controls
- Control of Materials
- Starting Materials
- Reagents, Solvents, Auxiliary Materials
- Control of Critical Steps and Intermediates
- Manufacturing Process Development
- S.3 Characterization
- Elucidation of Structure
- Other Characteristics
- Physicochemical properties
- Solid State Forms
- Impurities
- Types (organic, inorganic, residual solvents)
- Classification (specified/unspecified, identified/unidentified)
- Reporting, Identification and Qualification Thresholds
- Acceptance Criteria
- Qualification
- S.4 Control of the Drug Substance
- Specifications
- Analytical Procedures
- Validation of Analytical Procedures
- Batch Analyses
- Justification for Specifications
- S.5 Reference Standards
- S.6 Container Closure System
- S.7 Stability
- Stability Protocol and Data Evaluation
- Forced Degradation/Stress Testing
- Photostability
- Stability Summary and Conclusion
- Post-approval Stability Protocol and Commitment
- Stability Data
DAY TWO
Drug Master Files
- What are they
- Types of DMFs
- How are they used?
- When are they used?
- Information in a DMF vs. NDA
Requirements for the Drug Product
- P.1 Description and Composition
- P.2 Pharmaceutical Development
- Drug Substance
- Excipients
- Formulation Development
- Manufacturing Process Development
- Container Closure Suitability
- P.3 Manufacture
- Manufacturer
- Batch Formula
- Description of Manufacturing Process and Process Controls
- Control of Critical Steps and Intermediates
- P.4 Control of Excipients
- P.5 Control of the Drug Product
- Specifications (release, stability, in-house)
- Analytical Procedures
- Validation of Analytical Procedures
- Batch Analyses
- Justification of Specifications
- P.6 Reference Standards
- P.7 Container Closure Systems
- Primary, Secondary, Functional and Non-Functional Secondary Packaging
- P.8 Stability
- Stability Protocol and Data Evaluation
- Forced Degradation/Stress Testing
- Photostability
- Stability Summary and Conclusion
- Post-approval Stability Protocol and Commitment
- Stability Data
Regional Information
- Executed Batch Records
- Comparability Protocols
- Method Validation Package
Quality Overall Summary
FDA Interactions
-
Meetings and Preparations
- Questions
RETURN TO COURSE DESCRIPTION


|
|
|
Courses by Type I
Courses by Date I
Courses by Location I Certification Programs I Client Endorsements
On-Site Training I Course Catalog I
Course Locations & Transportation I
Accreditation I
About Us Press Releases I FAQs I Employment Opportunities I Site Map I Cancellation Policy
The Center for Professional Innovation & Education®
7 Great Valley Parkway, Suite 128
Malvern, PA 19355
Phone: 610-688-1708
|